Lambert Potin
Lambert Potin
Ph.D. in Biotechnology and Bioengineering
Verified email at
Cited by
Cited by
Lymph node stromal cells acquire peptide–MHCII complexes from dendritic cells and induce antigen-specific CD4+ T cell tolerance
J Dubrot, FV Duraes, L Potin, F Capotosti, D Brighouse, T Suter, ...
Journal of Experimental Medicine 211 (6), 1153-1166, 2014
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma
M Fankhauser, MAS Broggi, L Potin, N Bordry, L Jeanbart, AW Lund, ...
Science Translational Medicine 9 (407), eaal4712, 2017
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
A Mansurov, J Ishihara, P Hosseinchi, L Potin, TM Marchell, A Ishihara, ...
Nature biomedical engineering 4 (5), 531-543, 2020
Targeted antibody and cytokine cancer immunotherapies through collagen affinity
J Ishihara, A Ishihara, K Sasaki, SSY Lee, JM Williford, M Yasui, H Abe, ...
Science Translational Medicine 11 (487), eaau3259, 2019
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
J Ishihara, K Fukunaga, A Ishihara, HM Larsson, L Potin, P Hosseinchi, ...
Science Translational Medicine 9 (415), eaan0401, 2017
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy
JM Williford, J Ishihara, A Ishihara, A Mansurov, P Hosseinchi, ...
Science Advances 5 (12), eaay1357, 2019
Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients
MAS Broggi, L Maillat, CC Clement, N Bordry, P Corthésy, A Auger, ...
Journal of Experimental Medicine 216 (5), 1091-1107, 2019
Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
K Maisel, MS Sasso, L Potin, MA Swartz
Advanced Drug Delivery Reviews 114, 43-59, 2017
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity
J Ishihara, A Ishihara, L Potin, P Hosseinchi, K Fukunaga, M Damo, ...
Molecular cancer therapeutics 17 (11), 2399-2411, 2018
The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes
M Perreau, HC Welles, C Pellaton, B Gjoksi, L Potin, R Martin, A Harari, ...
Journal of virology 86 (11), 6279-6285, 2012
Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation
K Maisel, CL Hrusch, JEG Medellin, L Potin, DB Chapel, H Nurmi, ...
Mucosal immunology 14 (1), 144-151, 2021
Antigen presentation via MHC class II by lymphatic endothelial cells dampens CD4+ T cell response (IRC7P. 436)
L Potin, L Maillat, J Dubrot, F Duraes, S Hugues, M Swartz
The Journal of Immunology 194 (1_Supplement), 128.17-128.17, 2015
Lymphatic vessels regulate exosome trafficking from tumors
L Maillat, L Potin, WW Kilarski, MA Swartz
Cancer Research 79 (13_Supplement), 4520-4520, 2019
TGF-β Signaling Prevents MHC Class II–Expressing Lymphatic Endothelial Cells from Reactivating Human Allogenic Memory CD4+ T Cells
R Mezyk-Kopec, L Potin, JE Gomez Medellin, CM Salles, MA Swartz
The Journal of Immunology, 2023
Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen
MA Swartz, JA Hubbell, S Yu, E Vokali, M Fankhauser, S Hirosue, ...
US Patent 10,980,877, 2021
Abstract B97: The immunomodulatory roles of tumor-associated lymphatics in triple-negative breast cancer
P Hosseinchi, L Potin, A Mansurov, L Maillat, JA Hubbell, MA Swartz
Cancer Immunology Research 8 (3_Supplement), B97-B97, 2020
Collagen affinity improves safety and efficacy of antibody and cytokine cancer immunotherapies
J Ishihara, A Ishihara, A Mansurov, K Sasaki, SS Lee, JM Williford, L Potin, ...
Cancer Research 79 (13_Supplement), 1553-1553, 2019
Abstract IA07: Using matrix protein affinity to modulate the tumor microenvironment
J Ishihara, A Ishihara, K Saskai, SSY Lee, M Yasui, H Abe, L Potin, ...
Cancer Immunology Research 7 (2_Supplement), IA07-IA07, 2019
Inducing therapeutic lymphangiogenesis for potentiating cancer immunotherapy in melanoma
L Potin, L Maillat, PS Briquez, JA Hubbell, MA Swartz
Cancer Research 78 (13_Supplement), 1750-1750, 2018
13 Exploring mechanisms of tumour lymphangiogenesis to potentiate immunotherapies in melanoma
L Potin, L Maillat, PS Briquez, M Fankhauser, JA Hubbell, MA Swartz
ESMO Open 3, A6, 2018
The system can't perform the operation now. Try again later.
Articles 1–20